Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis.
暂无分享，去创建一个
P. Loria | J. Bauman | David A. Price | A. Kalgutkar | M. Boehm | J. Pfefferkorn | G. Tesz | B. Goodwin | Y. Lian | D. Kung | J. Gosset | C. Orozco | M. Niosi | Esther C Y Lee | Gregory J. Tesz | K. Futatsugi | Raman K. Sharma | J. Pettersen | K. Kou | Collin Crowley | Trenton T. Ross | R. Clark | S. Coffey | Shawn Cabral | J. Polívková | M. Dowling | K. Huard | R. Dullea | Qifang Li | H. Wisniewska | I. Stock | Anne-Marie R. Dechert-Schmitt | Allyn T. Londregan | David A. Price